Association of Essential Tremor With Novel Risk Loci: A Genome-Wide Association Study and Meta-analysis.


Journal

JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536

Informations de publication

Date de publication:
01 02 2022
Historique:
pubmed: 5 1 2022
medline: 9 3 2022
entrez: 4 1 2022
Statut: ppublish

Résumé

Essential tremor (ET) is one of the most common movement disorders, affecting 5% of the general population older than 65 years. Common variants are thought to contribute toward susceptibility to ET, but no variants have been robustly identified. To identify common genetic factors associated with risk of ET. Case-control genome-wide association study. Inverse-variance meta-analysis was used to combine cohorts. Multicenter samples collected from European populations were collected from January 2010 to September 2019 as part of an ongoing study. Included patients were clinically diagnosed with or reported having ET. Control individuals were not diagnosed with or reported to have ET. Of 485 250 individuals, data for 483 054 passed data quality control and were used. Genotypes of common variants associated with risk of ET. Of the 483 054 individuals included, there were 7177 with ET (3693 [51.46%] female; mean [SD] age, 62.66 [15.12] years), and 475 877 control individuals (253 785 [53.33%] female; mean [SD] age, 56.40 [17.6] years). Five independent genome-wide significant loci and were identified and were associated with approximately 18% of ET heritability. Functional analyses found significant enrichment in the cerebellar hemisphere, cerebellum, and axonogenesis pathways. Genetic correlation (r), which measures the degree of genetic overlap, revealed significant common variant overlap with Parkinson disease (r, 0.28; P = 2.38 × 10-8) and depression (r, 0.12; P = 9.78 × 10-4). A separate fine-mapping of transcriptome-wide association hits identified genes such as BACE2, LRRN2, DHRS13, and LINC00323 in disease-relevant brain regions, such as the cerebellum. The results of this genome-wide association study suggest that a portion of ET heritability can be explained by common genetic variation and can help identify new common genetic risk factors for ET.

Identifiants

pubmed: 34982113
pii: 2787239
doi: 10.1001/jamaneurol.2021.4781
pmc: PMC8728658
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

185-193

Commentaires et corrections

Type : ErratumIn

Auteurs

Calwing Liao (C)

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Charles-Etienne Castonguay (CE)

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Karl Heilbron (K)

23andMe, Inc, Sunnyvale, California.

Veikko Vuokila (V)

Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Miranda Medeiros (M)

Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Gabrielle Houle (G)

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Fulya Akçimen (F)

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Jay P Ross (JP)

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Helene Catoire (H)

Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Monica Diez-Fairen (M)

Fundació Docència i Recerca Mútua Terrassa, University Hospital Mútua de Terrassa, Terrassa, Barcelona, Spain.
Movement Disorders Unit, Department of Neurology, University Hospital Mútua de Terrassa, Terrassa, Barcelona, Spain.

Jooeun Kang (J)

Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tennessee.

Stefanie H Mueller (SH)

Institute of Health Informatics, University College London, London, United Kingdom.

Simon L Girard (SL)

Département des Sciences Fondamentales, Université du Québec à Chicoutimi, Saguenay, Quebec, Canada.
Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Franziska Hopfner (F)

Department of Neurology, Hannover Medical School, Hannover, Germany.

Delia Lorenz (D)

University Children's Hospital, University of Würzburg, Wurzburg, Germany.

Lorraine N Clark (LN)

Department of Pathology and Cell Biology, Taub Institute, Columbia University, New York, New York.

Alexandra I Soto-Beasley (AI)

Department of Neurology, Mayo Clinic Florida, Jacksonville.

Stephan Klebe (S)

Department of Neurology, University Hospital Würzburg, Wurzburg, Germany.
Department of Neurology, University Hospital Essen, Essen, Germany.

Mark Hallett (M)

National Institute of Neurological Disorders and Stroke Intramural Research Program, National Institutes of Health, Bethesda, Maryland.

Zbigniew K Wszolek (ZK)

Department of Neurology, Mayo Clinic Florida, Jacksonville.

Manuela Pendziwiat (M)

Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany.
Department of Neuropediatrics, University Medical Center Schleswig-Holstein, University of Kiel, Kiel, Germany.

Oswaldo Lorenzo-Betancor (O)

Veterans Affairs Puget Sound Health Care System, Seattle, Washington.
Department of Neurology, University of Washington School of Medicine, Seattle.

Klaus Seppi (K)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Daniela Berg (D)

Department of Neurology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.

Carles Vilariño-Güell (C)

Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

Ronald B Postuma (RB)

Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Geneviève Bernard (G)

Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Division of Pediatric Neurology, Departments of Pediatrics, Neurology and Neurosurgery, Montreal Children's Hospital, Montreal, Quebec, Canada.
Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Division of Medical Genetics, Department of Specialized Medicine, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.

Nicolas Dupré (N)

Faculté de Médecine, Université Laval, Centre Hospitalier Universitaire de Québec (l'Enfant-Jésus), Quebec, Canada.

Joseph Jankovic (J)

Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas.

Claudia M Testa (CM)

Parkinson's and Movement Disorders Center, Department of Neurology, Virginia Commonwealth University, Richmond.

Owen A Ross (OA)

Departments of Neuroscience and Clinical Genomics, Mayo Clinic Florida, Jacksonville.

Thomas Arzberger (T)

Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.

Sylvain Chouinard (S)

Unité des troubles du mouvement André Barbeau, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.

Elan D Louis (ED)

Department of Neurology, The University of Texas Southwestern Medical Center, Dallas.

Paola Mandich (P)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health (DINOGMI), University of Genoa, Genova, Italy.
Istituto di Ricovero e Cura a Carattere Scientifico Policlinico, San Martino, Genova, Italy.

Carmine Vitale (C)

Department of Motor Sciences and Wellness, University Parthenope, Naples, Italy.

Paolo Barone (P)

Center for Neurodegenerative Disease (CEMAND), Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Salerno, Italy.

Elena García-Martín (E)

University Institute of Molecular Pathology Biomarkers, UNEx, ARADyAL Instituto de Salud Carlos III, Caceres, Spain.

Hortensia Alonso-Navarro (H)

Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain.

José A G Agúndez (JAG)

University Institute of Molecular Pathology Biomarkers, UNEx, ARADyAL Instituto de Salud Carlos III, Caceres, Spain.

Félix Javier Jiménez-Jiménez (FJ)

Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain.

Pau Pastor (P)

Fundació Docència i Recerca Mútua Terrassa, University Hospital Mútua de Terrassa, Terrassa, Barcelona, Spain.

Alex Rajput (A)

University of Saskatchewan, Saskatoon Health Authority, Saskatoon, Saskatchewan, Canada.

Günther Deuschl (G)

Department of Neurology, University Medical Center Schleswig Holstein, University of Kiel, Kiel, Germany.

Gregor Kuhlenbaümer (G)

Department of Neurology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.

Inge A Meijer (IA)

Department of Neuroscience and Pediatrics, Université de Montréal, Montreal, Quebec, Canada.

Patrick A Dion (PA)

Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Guy A Rouleau (GA)

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH